DEVELOPING STRATEGY FOR BETTER HEALTH OUTCOMES FROM A PRODUCTIVE AND EFFICIENT RESEARCH ECOSYSTEM National Health and Medical Research Council (NHMRC) CEO Outlines Priorities
With
Professor Steve Wesselingh,
Chief Executive Officer,
National Health and Medical Research Council (NHMRC)
AUSTRALIAN HEALTH JOURNAL SEGMENT
Filmed in Canberra | June 2025
Professor Steve Wesselingh serves as the CEO of NHMRC, having initially trained as an infectious diseases doctor. His career includes prominent roles such as Head of the Infectious Diseases Unit at the Alfred Hospital, Director of the Burnett, Dean of Medicine at Monash University, and the inaugural Director of SAHMRI. Under his leadership, NHMRC plays a critical role in funding health and medical research, allocating approximately a billion dollars annually to investigator-led projects, clinical trials, and various strategic initiatives. NHMRC also collaborates internationally with organisations such as the MRC and the EU, and manages grant allocation for the MRFF, which distributes $650 million each year.
An important aspect of NHMRC’s mission is to ensure the integrity of research conducted in Australia, which is essential for maintaining public trust. The organisation oversees the accreditation of human research ethics committees nationwide and is involved in developing and endorsing clinical guidelines. Professor Wesselingh emphasises the urgency of promoting the benefits of health and medical research in the face of recent skepticism toward science and institutions.
Prof Wesselingh advocates for the integration of research into clinical care, arguing that such an approach enhances patient outcomes and promotes equity in access to innovative treatments across urban and rural areas. Each year, NHMRC hosts an awards event to recognise the achievements of Australia’s top researchers, underscoring the organisation’s commitment to advancing high-quality science and its impact on healthcare.
Currently NHMRC is developing a National Health and Medical Research Strategy that aims provide national direction, build on Australia’s strengths in the health and medical research sector, fill gaps, and continue to attract researchers and investors to Australia. Professor talks about Australia needing a national health and research strategy, echoed by groups such as Association of Australian Medical Research Institutes (AAMRI) in recent years. The formation of the strategy is underway under Ms Rosemary Huxtable AO PSM, as Chair of the National Strategy with the draft scheduled to be released by early July 2025.
Source: Written by AUDIENCED
-
Rural allied health mentorship program creates opportunities for students and practice
Melanie Roll, a director and physiotherapist at Gen Health Hamilton, is dedicated to nurturing the next generation of allied health professionals. Gen Health’s support begins with a work experience program for local secondary school students, where they can observe a variety of health services and participate in an annual careers night to explore allied health career pathways.
Upon moving to tertiary education, students are offered placements through a five-week program designed to transition them from observation to supervised practice and ultimately to seeing their own patients. In their final study year, they can apply for the mentorship program, which aids the transition into private practice.
-
The quest to create an Australian framework for a Palliative Care Pharmacist
Helen Stone is the State and Territory Manager SA & NT for the Pharmaceutical Society Australia. Her professional interests include palliative care, pharmacist professional services, mental health, leadership, and management.
She has recently led teams of pharmacists in innovative pharmacy practice models including in aged care, GP practice, palliative care and dementia support. This has contributed to the body of evidence for sustainable funding for embedded pharmacist roles in primary care and aged care settings.
-
Investments to address health inequities in Prostate Cancer Care
Income, education, geographical location, and discrimination based on ethnicity, race, gender and sexual orientation, are only a fraction of factors that can negatively affect a person’s quality of cancer care. This is defined as the “equity gap” and it’s costing people their lives.
Timed to coincide with World Cancer Day 4th February 2025, Movember announced prostate cancer investment of $5.5 million. Eighteen grants (16 proposals and 2 community development grants) are slated to directly tackle inequities in prostate cancer care. The funding will be over three years with the grants spread across five countries – six in Canada, five in the United Kingdom, three in Australia, three in the United States and one in Ireland – each having a specific focus population and care area.
